Assessment of second-line antiretroviral regimens for HIV therapy in Africa
BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-limited settings. Removing the NRTIs or replacing t...
Главные авторы: | Paton, N, Kityo, C, Walker, A, al., E |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Massachusetts Medical Society
2014
|
Схожие документы
-
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
по: Paton, N, и др.
Опубликовано: (2014) -
Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
по: Gomo, Z, и др.
Опубликовано: (2014) -
Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa
по: Boender, T, и др.
Опубликовано: (2016) -
Pediatric response to second-line antiretroviral therapy in South Africa.
по: Brian C Zanoni, и др.
Опубликовано: (2012-01-01) -
Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
по: Hakim, J, и др.
Опубликовано: (2017)